Molbio Diagnostics IPO: Temasek-backed diagnostics firm seeks ₹931 crore; should you apply?

Goa-based Molbio Diagnostics develops point-of-care diagnostic solutions. Its flagship Truenat platform, which is patented in more than 100 countries, enables rapid molecular testing for diseases including tuberculosis (TB), COVID-19, Hepatitis B and C, Human Immunodeficiency Virus (HIV) and Human Papillomavirus (HPV).

Leave a Reply

Your email address will not be published. Required fields are marked *